
201 - 500 employees
Founded 1992
𧬠Biotechnology
π Pharmaceuticals
π° $250M Post-IPO Debt - Geron on 2024-11
Biotechnology β’ Pharmaceuticals
Geron is a biotechnology company focused on developing medicines that inhibit telomerase to treat myeloid hematologic malignancies and other blood cancers. The company conducts research and development and clinical trials, reports an R&D pipeline and patient-focused programs, and notes that it has a medicine approved for use in the United States. Geron emphasizes a mission to extend and enhance patients' lives, corporate governance, and equal employment practices.
π July 7
Oncology Key Account Manager responsible for account management and relationship building with prescribers. Driving market share growth in the San Francisco Bay Area and surrounding regions.
π California β Remote
π΅ $195k - $205k / year
π° $250M Post-IPO Debt - Geron on 2024-11
β° Full Time
π Senior
π΄ Lead
π° Account Manager
π June 27
Oncology Key Account Manager engaging with academic centers and hospitals in Indiana and lower Michigan. Establishing relationships and driving market share growth in the oncology sector.
π Michigan β Remote
π΅ $195k - $205k / year
π° $250M Post-IPO Debt - Geron on 2024-11
β° Full Time
π Senior
π΄ Lead
π° Account Manager
π June 26
Regional Medical Scientific Director serves as a trusted partner to enhance medical education and generate data insights. Role involves maintaining scientific relationships within the territory.
π² North Carolina, South Carolina β Remote
π΅ $230k - $245k / year
π° $250M Post-IPO Debt - Geron on 2024-11
β° Full Time
π΄ Lead
π¨ββοΈ Medical Director
π June 25
Oncology Key Account Manager serving as the lead point of contact for account management activities. Focused on generating and expanding market share within the designated territory.
π€ Texas β Remote
π΅ $195k - $205k / year
π° $250M Post-IPO Debt - Geron on 2024-11
β° Full Time
π Senior
π΄ Lead
π° Account Manager